Skip to main content
Subscribe
Register
Sign in
Membership
Events
Knowledge Center
About
Subscribe
Register
Sign in
Premium
Alternative Insight and Premium Journalism
Latest Articles
Premium
Volatile Haidar Is Bullish Now
Stephen Taub
March 27, 2025
Premium
Seligman Slashes Market Exposure
Stephen Taub
March 26, 2025
A Veteran of Melvin Capital Preps New Vehicle
Stephen Taub
March 25, 2025
The Rich List: The 24th Annual Ranking of the Highest-Earning Hedge Fund Managers
Stephen Taub
March 21, 2025
Renaissance Continues to Surge
Stephen Taub
March 20, 2025
Premium
Senvest, Once a Top Performer, Struggles to Regain Its Status
Stephen Taub
March 19, 2025
Premium
Managed Futures Failed to Capitalize on Volatility and Market Sell-Off
Stephen Taub
March 18, 2025
Premium
Most Tiger-Related Funds Lost Money in February — But Are in the Black for the Year
Stephen Taub
March 17, 2025
Activist Irenic Capital Quickly Gains Ground
Stephen Taub
March 13, 2025
Biopharma Funds Are in Sick Bay
Stephen Taub
March 12, 2025
Robert Citrone Has Been Bearish This Year — And Now Discovery Is Net Short U.S. Stocks
Stephen Taub
March 11, 2025
Premium
Tesla’s U-Turn Stuns Hedgies
Stephen Taub
March 10, 2025
Premium
Third Point’s Surprising Pullback on Long Positions
Stephen Taub
March 6, 2025
Premium
Icahn’s Private Fund Posts Another Annual Loss
Stephen Taub
March 5, 2025
Taconic Passes the Hat for New Fund
Stephen Taub
March 4, 2025
David Einhorn’s Cautious Stock Market Stance Has Paid Off
Stephen Taub
March 3, 2025
Premium
Tiger Grandcub Sylebra, a Star in Early ’24, Suffers Big Loss
Stephen Taub
February 27, 2025
Premium
RFK Jr.’s Leadership of HHS Weighs on Biopharma
Stephen Taub
February 26, 2025
More Articles